Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free ELMD Stock Alerts

Electromed (ELMD) Financials

Electromed logo
$27.73 +0.22 (+0.80%)
As of 10:17 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Electromed

Annual Income Statements for Electromed

This table shows Electromed's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54 11
Consolidated Net Income / (Loss)		 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54 11
Net Income / (Loss) Continuing Operations		 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54 11
Total Pre-Tax Income 		3.04 3.52 2.73 2.92 5.24 3.17 3.00 4.09 7.04 10 14
Total Operating Income		 3.11 3.57 2.71 2.83 5.12 3.14 2.97 4.01 6.58 9.66 14
Total Gross Profit		 18 21 22 24 25 27 31 37 42 50 58
Total Revenue		 23 26 28 31 32 36 42 48 55 64 74
Operating Revenue		 23 26 28 31 32 36 42 48 55 64 74
Total Cost of Revenue		 5.12 5.29 6.53 7.45 7.27 8.45 10 12 13 14 16
Operating Cost of Revenue		 5.12 5.29 6.53 7.45 7.27 8.45 10 12 13 14 16
Total Operating Expenses		 15 17 19 21 20 24 28 33 35 40 44
Selling, General & Admin Expense		 14 16 19 20 20 22 27 32 34 39 43
Research & Development Expense		 0.38 0.60 0.25 0.58 1.05 1.72 1.36 0.92 0.66 1.00 1.31
Total Other Income / (Expense), net		 -0.07 -0.05 0.02 0.09 0.12 0.03 0.03 0.08 0.46 0.62 0.48
Interest & Investment Income		 - - - - - - - - 0.46 0.62 0.48
Income Tax Expense		 0.83 1.29 0.90 0.94 1.08 0.81 0.69 0.92 1.89 2.75 3.06
Basic Earnings per Share		 $0.27 $0.27 $0.22 $0.24 $0.50 $0.28 $0.27 $0.37 $0.60 $0.89 $1.37
Weighted Average Basic Shares Outstanding		 8.14M 8.17M 8.21M 8.31M 8.40M 8.57M 8.47M 8.46M 8.56M 8.45M 8.27M
Diluted Earnings per Share		 $0.27 $0.26 $0.21 $0.23 $0.47 $0.27 $0.26 $0.36 $0.58 $0.85 $1.30
Weighted Average Diluted Shares Outstanding		 8.25M 8.46M 8.62M 8.63M 8.83M 8.91M 8.77M 8.70M 8.86M 8.91M 8.69M
Weighted Average Basic & Diluted Shares Outstanding		 8.22M 8.26M 8.33M 8.44M 8.57M 8.59M 8.48M 8.56M 8.64M 8.35M 8.37M

Quarterly Income Statements for Electromed

This table shows Electromed's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00 3.40
Consolidated Net Income / (Loss)		 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00 3.40
Net Income / (Loss) Continuing Operations		 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00 3.40
Total Pre-Tax Income 		2.36 1.96 2.50 2.13 2.69 2.28 3.18 2.80 3.73 3.87 3.96
Total Operating Income		 2.26 1.84 2.34 1.94 2.54 2.14 3.04 2.67 3.62 3.77 3.83
Total Gross Profit		 11 10 11 11 13 12 14 13 15 15 15
Total Revenue		 14 14 15 15 16 16 17 17 19 19 19
Operating Revenue		 14 14 15 15 16 16 17 17 19 19 19
Total Cost of Revenue		 3.14 3.49 3.53 3.18 3.63 3.46 3.77 3.69 4.08 3.93 4.13
Operating Cost of Revenue		 3.14 3.49 3.53 3.18 3.63 3.46 3.77 3.69 4.08 3.93 4.13
Total Operating Expenses		 8.28 8.54 8.97 9.55 10 10 11 11 11 11 11
Selling, General & Admin Expense		 8.18 8.37 8.79 9.39 9.83 9.81 10 10 11 11 11
Research & Development Expense		 0.11 0.17 0.18 0.17 0.25 0.28 0.30 0.24 0.38 0.36 0.33
Total Other Income / (Expense), net		 0.10 0.12 0.16 0.20 0.15 0.14 0.14 0.13 0.11 0.10 0.14
Interest & Investment Income		 - 0.12 - 0.20 0.15 0.14 - 0.13 0.11 0.10 0.14
Income Tax Expense		 0.69 0.47 0.67 0.66 0.73 0.39 0.97 0.67 0.97 0.86 0.56
Basic Earnings per Share		 $0.20 $0.17 $0.21 $0.17 $0.23 $0.22 $0.27 $0.26 $0.33 $0.37 $0.41
Weighted Average Basic Shares Outstanding		 8.55M 8.57M 8.56M 8.56M 8.42M 8.50M 8.45M 8.32M 8.27M 8.21M 8.27M
Diluted Earnings per Share		 $0.19 $0.17 $0.20 $0.16 $0.22 $0.21 $0.26 $0.25 $0.32 $0.35 $0.38
Weighted Average Diluted Shares Outstanding		 8.80M 8.89M 8.86M 8.98M 8.95M 8.97M 8.91M 8.68M 8.69M 8.65M 8.69M
Weighted Average Basic & Diluted Shares Outstanding		 8.61M 8.66M 8.64M 8.46M 8.56M 8.39M 8.35M 8.34M 8.28M 8.28M 8.37M

Annual Cash Flow Statements for Electromed

This table details how cash moves in and out of Electromed's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 1.53 0.45 1.88 0.35 2.67 1.41 -3.74 -0.78 8.71 -0.79 5.16
Net Cash From Operating Activities		 2.17 1.19 2.44 2.59 4.20 3.08 -0.69 1.32 9.07 11 9.67
Net Cash From Continuing Operating Activities		 2.17 1.19 2.44 2.59 4.20 3.08 -0.69 1.32 9.07 11 9.67
Net Income / (Loss) Continuing Operations		 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54 11
Consolidated Net Income / (Loss)		 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54 11
Depreciation Expense		 0.62 0.64 0.68 0.80 0.62 0.48 0.50 0.55 0.79 1.04 0.87
Amortization Expense		 0.14 0.13 0.12 0.12 0.12 0.13 0.13 0.06 0.05 0.13 0.21
Non-Cash Adjustments To Reconcile Net Income		 0.28 0.62 0.91 0.72 1.00 2.60 1.35 0.78 1.46 2.95 2.66
Changes in Operating Assets and Liabilities, net		 -1.08 -2.42 -1.10 -1.04 -1.70 -2.50 -4.97 -3.25 1.62 -0.27 -5.38
Net Cash From Investing Activities		 -0.58 -0.69 -0.57 -1.39 -0.98 -0.45 -1.53 -1.72 -0.40 -0.31 -1.30
Net Cash From Continuing Investing Activities		 -0.58 -0.69 -0.57 -1.39 -0.98 -0.45 -1.53 -1.72 -0.40 -0.31 -1.30
Purchase of Property, Plant & Equipment		 -0.53 -0.62 -0.53 -1.33 -0.84 -0.29 -1.43 -1.65 -0.29 -0.26 -1.25
Acquisitions		 -0.04 -0.07 -0.05 -0.06 -0.13 -0.16 -0.10 -0.07 -0.11 -0.04 -0.05
Net Cash From Financing Activities		 -0.06 -0.05 0.01 -0.85 -0.55 -1.22 -1.53 -0.38 0.04 -12 -3.20
Net Cash From Continuing Financing Activities		 -0.06 -0.05 0.01 -0.85 -0.55 -1.22 -1.53 -0.38 0.04 -12 -3.20
Repurchase of Common Equity		 - - - - 0.00 -1.12 -1.45 -0.15 -0.28 -10 -3.92
Other Financing Activities, net		 - - 0.06 0.25 -0.63 -0.14 -0.08 -0.31 0.31 -1.88 0.72

Quarterly Cash Flow Statements for Electromed

This table details how cash moves in and out of Electromed's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 3.41 1.28 4.37 -2.22 2.37 -1.00 0.05 -1.17 -0.32 3.19 3.47
Net Cash From Operating Activities		 3.47 1.35 4.49 2.31 3.15 2.07 3.86 0.17 3.03 3.48 2.99
Net Cash From Continuing Operating Activities		 3.47 1.35 4.49 2.31 3.15 2.07 3.86 0.17 3.03 3.48 2.99
Net Income / (Loss) Continuing Operations		 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00 3.40
Consolidated Net Income / (Loss)		 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00 3.40
Depreciation Expense		 0.20 0.20 0.20 0.20 0.21 0.25 0.38 0.21 0.21 0.22 0.23
Amortization Expense		 0.01 0.01 0.02 0.02 0.06 0.03 0.02 0.05 0.05 0.07 0.05
Non-Cash Adjustments To Reconcile Net Income		 1.35 0.60 1.27 0.66 2.19 0.63 0.95 0.32 0.67 0.96 0.70
Changes in Operating Assets and Liabilities, net		 0.24 -0.95 1.18 -0.05 -1.27 -0.73 0.31 -2.55 -0.67 -0.78 -1.38
Net Cash From Investing Activities		 -0.09 -0.13 -0.05 -0.06 -0.24 0.15 -0.16 -0.27 -0.66 -0.15 -0.22
Net Cash From Continuing Investing Activities		 -0.09 -0.13 -0.05 -0.06 -0.24 0.15 -0.16 -0.27 -0.66 -0.15 -0.22
Purchase of Property, Plant & Equipment		 -0.07 -0.09 -0.02 -0.04 -0.23 0.15 -0.15 -0.25 -0.63 -0.15 -0.22
Acquisitions		 -0.02 -0.04 -0.02 -0.02 -0.00 -0.01 -0.01 -0.02 -0.02 -0.01 -0.00
Net Cash From Financing Activities		 0.03 0.06 -0.08 -4.47 -0.54 -3.22 -3.65 -1.08 -2.69 -0.13 0.69
Net Cash From Continuing Financing Activities		 0.03 0.06 -0.08 -4.47 -0.54 -3.22 -3.65 -1.08 -2.69 -0.13 0.69
Other Financing Activities, net		 - 0.11 - 0.07 -0.81 -1.42 0.02 -0.07 0.07 0.02 0.69

Annual Balance Sheets for Electromed

This table presents Electromed's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 21 23 8.93 29 33 37 41 46 52 54 66
Total Current Assets		 16 18 8.23 25 28 32 35 38 44 45 57
Cash & Equivalents		 5.12 5.57 7.46 7.81 10 12 8.15 7.37 16 15 20
Accounts Receivable		 7.61 9.95 - 13 13 17 21 24 23 25 30
Inventories, net		 2.48 2.56 - 2.62 3.09 2.11 3.18 4.22 3.71 3.30 3.68
Prepaid Expenses		 0.42 0.39 - 0.35 0.35 0.28 1.87 1.58 0.33 0.39 1.17
Current Deferred & Refundable Income Taxes		 0.19 - - 0.00 0.26 - - - 0.00 0.41 1.17
Other Current Assets		 - - 0.78 1.00 0.90 0.39 0.29 0.49 0.72 1.04 1.09
Plant, Property, & Equipment, net		 3.38 3.30 0.00 3.60 3.79 3.61 4.57 5.67 5.17 4.71 5.21
Total Noncurrent Assets		 1.37 1.28 0.69 1.26 1.43 1.80 2.26 2.35 2.90 4.01 3.69
Intangible Assets		 0.90 0.72 0.65 0.58 0.60 0.66 0.60 0.61 0.66 0.37 0.38
Noncurrent Deferred & Refundable Income Taxes		 0.34 0.46 - 0.63 0.76 1.05 1.54 1.58 2.15 2.46 2.04
Other Noncurrent Operating Assets		 0.13 0.10 0.05 0.05 0.08 0.09 0.12 0.16 0.09 1.17 1.27
Total Liabilities & Shareholders' Equity		 21 23 10 29 33 37 41 46 52 54 66
Total Liabilities		 4.22 3.99 0.81 3.67 3.00 4.69 7.19 8.14 7.69 11 12
Total Current Liabilities		 3.07 2.90 0.79 3.65 2.99 4.64 7.15 8.05 7.68 10 12
Accounts Payable		 0.59 0.66 - 0.59 0.56 0.69 1.26 1.37 1.01 2.67 2.64
Accrued Expenses		 0.66 0.64 0.76 0.81 0.74 0.94 1.26 1.38 2.50 2.72 3.51
Current Employee Benefit Liabilities		 1.49 0.95 - 1.40 1.40 2.47 2.74 3.02 3.89 5.08 6.07
Total Noncurrent Liabilities		 1.15 1.10 0.01 0.01 0.01 0.05 0.04 0.09 0.01 0.13 0.07
Other Noncurrent Operating Liabilities		 - - - 0.01 - - - - 0.01 0.13 0.07
Total Equity & Noncontrolling Interests		 16 19 9.52 26 30 32 34 38 45 43 54
Total Preferred & Common Equity		 16 19 9.52 26 30 32 34 38 45 43 54
Total Common Equity		 16 19 9.52 26 30 32 34 38 45 43 54
Common Stock		 14 14 - 16 17 17 18 19 21 22 25
Retained Earnings		 2.73 4.96 9.52 9.52 14 15 16 19 24 21 29

Quarterly Balance Sheets for Electromed

This table presents Electromed's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 44 47 49 49 52 52 54 55 59
Total Current Assets		 36 39 41 41 44 44 45 46 50
Cash & Equivalents		 7.02 10 12 14 16 15 14 14 17
Accounts Receivable		 23 23 24 22 23 23 25 26 28
Inventories, net		 4.48 4.76 4.18 3.43 3.08 2.97 3.77 3.46 3.30
Prepaid Expenses		 0.69 0.51 0.59 0.59 0.59 0.49 0.54 0.91 0.60
Current Deferred & Refundable Income Taxes		 - - 0.29 - 0.51 0.93 0.21 0.00 0.02
Other Current Assets		 0.54 0.57 0.64 0.75 1.00 1.12 1.17 1.15 1.09
Plant, Property, & Equipment, net		 5.53 5.38 5.28 5.00 5.22 4.81 4.98 5.22 5.21
Total Noncurrent Assets		 2.34 2.32 2.30 2.90 2.87 3.44 4.08 4.13 4.04
Intangible Assets		 0.61 0.62 0.65 0.66 0.61 0.59 0.39 0.39 0.35
Noncurrent Deferred & Refundable Income Taxes		 1.58 1.58 1.54 2.15 2.15 2.15 2.46 2.46 2.46
Other Noncurrent Operating Assets		 0.14 0.13 0.11 0.09 0.11 0.70 1.23 1.28 1.22
Total Liabilities & Shareholders' Equity		 44 47 49 49 52 52 54 55 59
Total Liabilities		 5.84 6.62 6.36 7.43 8.67 8.51 8.87 9.47 10
Total Current Liabilities		 5.78 6.57 6.33 7.42 8.67 8.51 8.76 9.38 10
Accounts Payable		 1.06 1.04 0.79 1.78 1.51 1.88 3.14 2.32 2.60
Accrued Expenses		 1.42 1.48 1.53 1.64 1.60 2.66 2.89 2.96 3.10
Current Employee Benefit Liabilities		 1.84 2.81 2.99 2.15 3.62 3.97 2.73 3.71 4.53
Total Noncurrent Liabilities		 0.07 0.05 0.03 0.01 0.00 0.00 0.11 0.10 0.08
Other Noncurrent Operating Liabilities		 - - - - - 0.00 0.11 0.10 0.08
Total Equity & Noncontrolling Interests		 38 40 43 41 44 44 45 45 49
Total Preferred & Common Equity		 38 40 43 41 44 44 45 45 49
Total Common Equity		 38 40 43 41 44 44 45 45 49
Common Stock		 19 20 20 21 21 21 22 23 24
Retained Earnings		 19 21 22 21 23 23 22 22 25

Annual Metrics And Ratios for Electromed

This table displays calculated financial ratios and metrics derived from Electromed's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 8,187,112.00 8,230,167.00 8,288,659.00 8,408,351.00 8,483,785.00 8,637,420.00 8,513,035.00 8,561,100.00 - 8,386,115.00 8,280,064.00
DEI Adjusted Shares Outstanding		 8,187,112.00 8,230,167.00 8,288,659.00 8,408,351.00 8,483,785.00 8,637,420.00 8,513,035.00 8,561,100.00 - 8,386,115.00 8,280,064.00
DEI Earnings Per Adjusted Shares Outstanding		 0.27 0.27 0.22 0.24 0.49 0.27 0.27 0.37 - 0.90 1.36
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 18.46% 12.48% 9.46% 10.57% 3.74% 10.12% 16.51% 15.38% 13.83% 16.97% 15.28%
EBITDA Growth		 87.16% 12.20% -19.11% 7.07% 55.96% -36.00% -4.00% 28.36% 60.61% 45.94% 38.08%
EBIT Growth		 137.32% 14.80% -24.01% 4.33% 80.87% -38.65% -5.35% 34.86% 64.20% 46.79% 43.70%
NOPAT Growth		 93.43% 0.00% -19.60% 5.55% 111.84% -42.39% -2.40% 35.86% 55.11% 46.97% 54.30%
Net Income Growth		 102.52% 0.77% -17.87% 8.15% 110.12% -43.23% -2.41% 37.35% 62.67% 46.35% 49.94%
EPS Growth		 107.69% -3.70% -19.23% 9.52% 104.35% -42.55% -3.70% 38.46% 61.11% 46.55% 52.94%
Operating Cash Flow Growth		 -22.09% -45.03% 105.03% 6.05% 62.02% -26.67% -122.29% 291.69% 589.51% 25.65% -15.17%
Free Cash Flow Firm Growth		 -33.14% -96.64% 33,170.19% -197.32% 114.15% -25.65% -298.05% 61.98% 653.42% 13.21% -30.25%
Invested Capital Growth		 7.36% 17.81% -95.15% 2,427.71% 10.56% 3.67% 26.63% 16.58% -6.27% -1.91% 20.08%
Revenue Q/Q Growth		 2.20% 6.51% 2.16% 2.39% -5.05% 7.81% 4.52% 5.12% 2.28% 4.17% 2.82%
EBITDA Q/Q Growth		 3.77% 29.06% -6.23% 9.36% -5.28% -15.09% -4.08% 28.86% 13.11% 8.97% 4.62%
EBIT Q/Q Growth		 4.42% 37.60% -8.43% 8.58% -3.74% -16.89% -4.99% 33.20% 14.65% 7.87% 5.99%
NOPAT Q/Q Growth		 -24.07% 36.50% -0.90% 7.44% 5.90% -27.67% -0.92% 25.11% 17.04% 6.05% 12.06%
Net Income Q/Q Growth		 3.86% 37.60% 0.41% 7.36% 5.54% -27.79% -0.69% 25.83% 18.25% 5.25% 11.85%
EPS Q/Q Growth		 3.85% 36.84% 0.00% 9.52% 2.17% -25.00% -3.70% 28.57% 16.00% 7.59% 10.17%
Operating Cash Flow Q/Q Growth		 -17.31% -8.55% 8.21% 48.64% -3.10% -14.71% -185.11% 410.87% 62.58% -5.24% -8.21%
Free Cash Flow Firm Q/Q Growth		 -48.55% -59.39% 1,414.68% -2,620.25% 72.15% -28.64% -123.42% 58.93% 131.72% -13.73% -15.19%
Invested Capital Q/Q Growth		 1.60% 6.31% -95.12% 6.15% 1.83% 0.53% 7.65% 2.47% -7.73% -2.72% 4.19%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 77.75% 79.53% 76.92% 76.19% 77.61% 76.36% 75.47% 75.98% 76.26% 78.08% 78.54%
EBITDA Margin		 16.81% 16.77% 12.40% 12.00% 18.04% 10.49% 8.64% 9.61% 13.56% 16.93% 20.27%
Operating Margin		 13.52% 13.80% 9.58% 9.04% 15.76% 8.78% 7.13% 8.34% 12.03% 15.09% 18.82%
EBIT Margin		 13.52% 13.80% 9.58% 9.04% 15.76% 8.78% 7.13% 8.34% 12.03% 15.09% 18.82%
Profit (Net Income) Margin		 9.62% 8.62% 6.47% 6.33% 12.81% 6.61% 5.53% 6.59% 9.41% 11.78% 15.32%
Tax Burden Percent		 72.72% 63.35% 67.02% 67.81% 79.42% 74.58% 76.91% 77.48% 73.20% 73.29% 78.70%
Interest Burden Percent		 97.85% 98.60% 100.73% 103.21% 102.36% 100.86% 100.84% 101.95% 106.91% 106.46% 103.45%
Effective Tax Rate		 27.28% 36.65% 32.98% 32.19% 20.58% 25.42% 23.09% 22.52% 26.81% 26.71% 21.30%
Return on Invested Capital (ROIC)		 18.84% 16.71% 23.68% 20.56% 21.50% 11.58% 9.80% 11.00% 16.37% 25.11% 35.55%
ROIC Less NNEP Spread (ROIC-NNEP)		 20.39% 17.46% 23.48% 19.82% 20.45% 11.40% 9.61% 10.22% 13.52% 22.20% 33.44%
Return on Net Nonoperating Assets (RNNOA)		 -4.23% -4.12% -10.87% -9.32% -6.64% -4.05% -2.88% -2.19% -3.84% -7.93% -12.30%
Return on Equity (ROE)		 14.61% 12.59% 12.81% 11.23% 14.87% 7.54% 6.92% 8.81% 12.53% 17.18% 23.26%
Cash Return on Invested Capital (CROIC)		 11.74% 0.35% 205.17% -164.22% 11.48% 7.98% -13.70% -4.30% 22.84% 27.04% 17.31%
Operating Return on Assets (OROA)		 16.37% 16.36% 16.96% 14.77% 16.34% 8.93% 7.57% 9.20% 13.43% 18.22% 23.12%
Return on Assets (ROA)		 11.65% 10.22% 11.45% 10.33% 13.28% 6.71% 5.87% 7.26% 10.51% 14.22% 18.82%
Return on Common Equity (ROCE)		 14.61% 12.59% 12.81% 11.23% 14.87% 7.54% 6.92% 8.81% 12.53% 17.18% 23.26%
Return on Equity Simple (ROE_SIMPLE)		 13.53% 11.69% 19.23% 7.70% 13.76% 7.29% 6.75% 8.41% 11.56% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 2.26 2.26 1.82 1.92 4.06 2.34 2.29 3.11 4.82 7.08 11
NOPAT Margin		 9.83% 8.74% 6.42% 6.13% 12.52% 6.55% 5.49% 6.46% 8.80% 11.06% 14.81%
Net Nonoperating Expense Percent (NNEP)		 -1.55% -0.76% 0.20% 0.74% 1.06% 0.18% 0.19% 0.79% 2.85% 2.92% 2.11%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - 16.38% 20.24%
Cost of Revenue to Revenue		 22.25% 20.47% 23.08% 23.81% 22.39% 23.64% 24.53% 24.02% 23.74% 21.92% 21.46%
SG&A Expenses to Revenue		 62.57% 63.42% 66.45% 65.29% 61.42% 62.77% 65.09% 65.73% 63.03% 61.43% 57.94%
R&D to Revenue		 1.65% 2.31% 0.89% 1.86% 3.23% 4.82% 3.26% 1.91% 1.20% 1.56% 1.78%
Operating Expenses to Revenue		 64.23% 65.73% 67.34% 67.15% 61.85% 67.58% 68.34% 67.64% 64.23% 62.99% 59.72%
Earnings before Interest and Taxes (EBIT)		 3.11 3.57 2.71 2.83 5.12 3.14 2.97 4.01 6.58 9.66 14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3.87 4.34 3.51 3.76 5.86 3.75 3.60 4.62 7.42 11 15
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.93 2.39 4.72 1.78 4.32 3.01 2.40 2.43 2.92 4.27 6.49
Price to Tangible Book Value (P/TBV)		 2.04 2.48 5.06 1.82 4.40 3.07 2.44 2.47 2.96 4.30 6.53
Price to Revenue (P/Rev)		 1.37 1.76 1.59 1.46 4.02 2.73 1.97 1.91 2.38 2.88 4.75
Price to Earnings (P/E)		 14.28 20.41 24.53 23.14 31.38 41.29 35.60 28.96 25.26 24.47 30.99
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 7.00% 4.90% 4.08% 4.32% 3.19% 2.42% 2.81% 3.45% 3.96% 4.09% 3.23%
Enterprise Value to Invested Capital (EV/IC)		 2.23 2.81 52.81 2.12 6.05 4.16 2.84 2.78 4.00 6.06 9.84
Enterprise Value to Revenue (EV/Rev)		 1.20 1.59 1.33 1.22 3.70 2.40 1.78 1.76 2.08 2.64 4.47
Enterprise Value to EBITDA (EV/EBITDA)		 7.16 9.47 10.69 10.13 20.51 22.85 20.54 18.27 15.36 15.61 22.05
Enterprise Value to EBIT (EV/EBIT)		 8.90 11.51 13.83 13.45 23.48 27.29 24.88 21.06 17.33 17.51 23.76
Enterprise Value to NOPAT (EV/NOPAT)		 12.24 18.17 20.64 19.83 29.56 36.59 32.35 27.18 23.67 23.89 30.19
Enterprise Value to Operating Cash Flow (EV/OCF)		 12.77 34.49 15.36 14.69 28.64 27.85 0.00 64.19 12.58 14.84 34.12
Enterprise Value to Free Cash Flow (EV/FCFF)		 19.63 867.96 2.38 0.00 55.40 53.12 0.00 0.00 16.97 22.19 62.03
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.07 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.07 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.21 -0.24 -0.46 -0.47 -0.32 -0.35 -0.30 -0.21 -0.28 -0.36 -0.37
Leverage Ratio		 1.25 1.23 1.12 1.09 1.12 1.12 1.18 1.21 1.19 1.21 1.24
Compound Leverage Factor		 1.23 1.21 1.13 1.12 1.15 1.13 1.19 1.24 1.28 1.29 1.28
Debt to Total Capital		 6.80% 5.68% 0.47% 0.12% 0.27% 0.17% 0.12% 0.23% 0.03% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.26% 0.25% 0.32% 0.12% 0.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 6.53% 5.43% 0.15% 0.00% 0.03% 0.17% 0.12% 0.23% 0.03% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 93.20% 94.32% 99.53% 99.88% 99.73% 99.83% 99.88% 99.77% 99.97% 100.00% 100.00%
Debt to EBITDA		 0.31 0.26 0.01 0.01 0.01 0.01 0.01 0.02 0.00 0.00 0.00
Net Debt to EBITDA		 -1.02 -1.02 -2.11 -2.07 -1.77 -3.16 -2.25 -1.58 -2.16 0.00 0.00
Long-Term Debt to EBITDA		 0.30 0.25 0.00 0.00 0.00 0.01 0.01 0.02 0.00 0.00 0.00
Debt to NOPAT		 0.53 0.51 0.02 0.02 0.02 0.02 0.02 0.03 0.00 0.00 0.00
Net Debt to NOPAT		 -1.74 -1.96 -4.08 -4.05 -2.56 -5.05 -3.55 -2.35 -3.34 0.00 0.00
Long-Term Debt to NOPAT		 0.51 0.49 0.01 0.00 0.00 0.02 0.02 0.03 0.00 0.00 0.00
Altman Z-Score		 7.04 9.58 40.15 10.19 29.12 15.15 9.42 9.45 13.09 13.55 20.33
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.15 6.38 10.42 6.72 9.38 6.83 4.83 4.69 5.75 4.31 4.69
Quick Ratio		 4.14 5.36 9.43 5.63 7.84 6.23 4.08 3.91 5.13 3.82 4.11
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1.41 0.05 16 -15 2.17 1.61 -3.19 -1.21 6.72 7.62 5.32
Operating Cash Flow to CapEx		 405.07% 192.50% 464.10% 194.90% 497.16% 1,072.13% -48.14% 79.79% 3,159.23% 4,348.47% 771.96%
Free Cash Flow to Firm to Interest Expense		 21.10 0.95 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 32.44 23.89 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 24.43 11.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.21 1.19 1.77 1.63 1.04 1.02 1.06 1.10 1.12 1.21 1.23
Accounts Receivable Turnover		 3.25 2.95 0.00 0.00 2.53 2.39 2.19 2.13 2.31 2.67 2.71
Inventory Turnover		 2.25 2.10 0.00 0.00 2.55 3.25 3.86 3.12 3.27 4.00 4.54
Fixed Asset Turnover		 6.56 7.74 0.00 0.00 8.78 9.67 10.19 9.39 10.10 12.96 14.86
Accounts Payable Turnover		 9.07 8.45 0.00 0.00 12.73 13.62 10.50 8.77 10.91 7.63 5.96
Days Sales Outstanding (DSO)		 112.16 123.93 0.00 0.00 144.45 152.98 166.84 171.55 158.31 136.86 134.73
Days Inventory Outstanding (DIO)		 162.41 173.78 0.00 0.00 143.24 112.27 94.53 116.93 111.45 91.20 80.46
Days Payable Outstanding (DPO)		 40.23 43.19 0.00 0.00 28.68 26.80 34.76 41.61 33.47 47.83 61.21
Cash Conversion Cycle (CCC)		 234.34 254.52 0.00 0.00 259.02 238.46 226.61 246.87 236.30 180.23 153.98
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 12 15 0.71 18 20 21 26 30 28 28 34
Invested Capital Turnover		 1.92 1.91 3.69 3.35 1.72 1.77 1.79 1.70 1.86 2.27 2.40
Increase / (Decrease) in Invested Capital		 0.85 2.21 -14 17 1.90 0.73 5.48 4.32 -1.90 -0.54 5.61
Enterprise Value (EV)		 28 41 38 38 120 86 74 84 114 169 330
Market Capitalization		 32 46 45 46 131 98 82 92 130 184 350
Book Value per Share		 $2.00 $2.32 $1.15 $3.06 $3.57 $3.75 $4.01 $4.40 $5.15 $5.15 $6.52
Tangible Book Value per Share		 $1.89 $2.23 $1.07 $2.99 $3.50 $3.68 $3.94 $4.33 $5.07 $5.11 $6.47
Total Capital		 18 20 9.57 26 30 32 34 38 45 43 54
Total Debt		 1.19 1.15 0.05 0.03 0.08 0.05 0.04 0.09 0.01 0.00 0.00
Total Long-Term Debt		 1.15 1.10 0.01 0.00 0.01 0.05 0.04 0.09 0.01 0.00 0.00
Net Debt		 -3.93 -4.43 -7.41 -7.78 -10 -12 -8.11 -7.29 -16 -15 -20
Capital Expenditures (CapEx)		 0.53 0.62 0.53 1.33 0.84 0.29 1.43 1.65 0.29 0.26 1.25
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 7.68 10 0.02 13 15 15 19 22 20 19 25
Debt-free Net Working Capital (DFNWC)		 13 16 7.47 21 25 27 27 30 36 35 45
Net Working Capital (NWC)		 13 16 7.44 21 25 27 27 30 36 35 45
Net Nonoperating Expense (NNE)		 0.05 0.03 -0.01 -0.06 -0.10 -0.02 -0.02 -0.06 -0.33 -0.46 -0.38
Net Nonoperating Obligations (NNO)		 -3.93 -4.43 -8.81 -7.78 -10 -12 -8.11 -7.29 -16 -15 -20
Total Depreciation and Amortization (D&A)		 0.76 0.77 0.80 0.93 0.74 0.61 0.63 0.61 0.84 1.17 1.08
Debt-free, Cash-free Net Working Capital to Revenue		 33.39% 38.89% 0.06% 41.89% 45.06% 42.44% 46.17% 46.52% 37.31% 30.20% 33.47%
Debt-free Net Working Capital to Revenue		 55.68% 60.44% 26.40% 66.83% 77.33% 75.69% 65.75% 61.86% 66.70% 54.08% 61.19%
Net Working Capital to Revenue		 55.48% 60.25% 26.29% 66.74% 77.11% 75.69% 65.75% 61.86% 66.70% 54.08% 61.19%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.27 $0.27 $0.23 $0.24 $0.50 $0.28 $0.27 $0.37 $0.60 $0.89 $1.37
Adjusted Weighted Average Basic Shares Outstanding		 8.14M 8.17M 8.21M 8.31M 8.40M 8.57M 8.47M 8.46M 8.56M 8.45M 8.27M
Adjusted Diluted Earnings per Share		 $0.27 $0.26 $0.22 $0.23 $0.47 $0.27 $0.26 $0.36 $0.58 $0.85 $1.30
Adjusted Weighted Average Diluted Shares Outstanding		 8.25M 8.46M 8.62M 8.63M 8.83M 8.91M 8.77M 8.70M 8.86M 8.91M 8.69M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 8.22M 8.26M 8.33M 8.44M 8.57M 8.59M 8.48M 8.56M 8.64M 8.35M 8.37M
Normalized Net Operating Profit after Tax (NOPAT)		 2.26 2.26 1.82 1.92 4.06 2.34 2.29 3.11 4.82 7.08 11
Normalized NOPAT Margin		 9.83% 8.74% 6.42% 6.13% 12.52% 6.55% 5.49% 6.46% 8.80% 11.06% 14.81%
Pre Tax Income Margin		 13.23% 13.61% 9.65% 9.33% 16.13% 8.86% 7.19% 8.50% 12.86% 16.07% 19.46%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 46.54 71.58 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 33.85 45.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 38.53 59.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 25.84 32.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 47.59% 62.82% 4.83% 5.34% 132.68% 34.67%

Quarterly Metrics And Ratios for Electromed

This table displays calculated financial ratios and metrics derived from Electromed's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 8,581,677.00 8,605,227.00 - - - 8,556,844.00 8,386,115.00 8,349,176.00 8,340,538.00 8,275,313.00 8,280,064.00
DEI Adjusted Shares Outstanding		 8,581,677.00 8,605,227.00 - - - 8,556,844.00 8,386,115.00 8,349,176.00 8,340,538.00 8,275,313.00 8,280,064.00
DEI Earnings Per Adjusted Shares Outstanding		 0.20 0.17 - - - 0.22 0.26 0.26 0.33 0.36 0.41
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 16.71% 14.94% 8.96% 19.02% 18.75% 13.07% 17.27% 15.13% 16.25% 18.43% 11.64%
EBITDA Growth		 71.79% 57.74% 51.04% 506.18% 13.84% 18.25% 35.05% 35.73% 37.81% 67.27% 19.20%
EBIT Growth		 77.63% 53.93% 56.29% 1,264.79% 12.33% 16.24% 30.19% 37.77% 42.41% 75.98% 25.82%
NOPAT Growth		 65.27% 33.22% 70.02% 1,232.55% 15.64% 26.52% 23.45% 51.87% 44.34% 64.96% 55.63%
Net Income Growth		 71.34% 38.88% 76.96% 850.97% 17.56% 26.66% 20.57% 44.91% 40.29% 58.80% 54.31%
EPS Growth		 72.73% 41.67% 66.67% 700.00% 15.79% 23.53% 30.00% 56.25% 45.45% 66.67% 46.15%
Operating Cash Flow Growth		 154.47% 109.13% 349.35% 1,046.31% -9.22% 53.52% -14.03% -92.68% -3.97% 67.60% -22.42%
Free Cash Flow Firm Growth		 -196.28% 104.25% 209.02% 115.96% 115.67% 2,007.46% -26.81% -119.43% -135.92% -114.08% -187.54%
Invested Capital Growth		 0.00% 4.10% -6.27% -11.62% -8.63% -7.00% -1.91% 10.86% 15.62% 12.12% 20.08%
Revenue Q/Q Growth		 11.08% 1.33% 6.93% -1.11% 10.82% -3.51% 10.90% -2.91% 11.90% -1.70% 4.53%
EBITDA Q/Q Growth		 594.38% -17.11% 24.21% -15.21% 30.40% -13.89% 41.85% -14.78% 32.40% 4.51% 1.09%
EBIT Q/Q Growth		 1,493.66% -18.65% 26.83% -17.00% 31.17% -15.81% 42.06% -12.17% 35.58% 4.03% 1.57%
NOPAT Q/Q Growth		 1,497.85% -12.72% 21.96% -21.65% 38.66% -4.50% 19.00% -3.62% 31.78% 9.14% 12.27%
Net Income Q/Q Growth		 980.00% -10.81% 22.44% -19.37% 33.51% -3.91% 16.55% -3.09% 29.26% 8.76% 13.25%
EPS Q/Q Growth		 850.00% -10.53% 17.65% -20.00% 37.50% -4.55% 23.81% -3.85% 28.00% 9.38% 8.57%
Operating Cash Flow Q/Q Growth		 1,522.54% -61.08% 232.27% -48.56% 36.47% -34.18% 86.07% -95.62% 1,690.53% 14.87% -13.87%
Free Cash Flow Firm Q/Q Growth		 9.03% 100.66% 1,836.04% 37.63% -10.68% -11.45% -32.54% -136.41% -65.17% 65.30% -319.52%
Invested Capital Q/Q Growth		 -4.19% 3.02% -7.73% -2.97% -0.94% 4.86% -2.72% 9.71% 3.32% 1.69% 4.19%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 77.03% 74.85% 76.19% 78.34% 77.68% 77.97% 78.33% 78.15% 78.42% 78.83% 78.71%
EBITDA Margin		 18.06% 14.77% 17.16% 14.71% 17.31% 15.45% 19.76% 17.34% 20.52% 21.82% 21.10%
Operating Margin		 16.53% 13.27% 15.74% 13.21% 15.64% 13.64% 17.48% 15.81% 19.16% 20.27% 19.70%
EBIT Margin		 16.53% 13.27% 15.74% 13.21% 15.64% 13.64% 17.48% 15.81% 19.16% 20.27% 19.70%
Profit (Net Income) Margin		 12.23% 10.76% 12.32% 10.05% 12.11% 12.06% 12.67% 12.65% 14.61% 16.17% 17.52%
Tax Burden Percent		 70.96% 76.13% 73.21% 69.10% 73.05% 82.87% 69.42% 76.18% 74.04% 77.68% 85.86%
Interest Burden Percent		 104.24% 106.52% 106.94% 110.06% 105.98% 106.64% 104.44% 105.02% 103.01% 102.66% 103.56%
Effective Tax Rate		 29.04% 23.87% 26.79% 30.90% 26.95% 17.13% 30.58% 23.82% 25.96% 22.32% 14.14%
Return on Invested Capital (ROIC)		 40.49% 17.87% 21.43% 17.69% 23.76% 23.32% 27.54% 27.38% 33.10% 37.12% 40.61%
ROIC Less NNEP Spread (ROIC-NNEP)		 39.17% 16.88% 20.41% 16.40% 22.93% 22.45% 26.94% 26.65% 32.56% 36.64% 39.96%
Return on Net Nonoperating Assets (RNNOA)		 -10.08% -3.94% -5.80% -4.28% -7.27% -6.99% -9.63% -8.64% -10.98% -12.68% -14.69%
Return on Equity (ROE)		 30.40% 13.93% 15.63% 13.41% 16.49% 16.34% 17.91% 18.73% 22.12% 24.44% 25.92%
Cash Return on Invested Capital (CROIC)		 -174.90% 9.59% 22.84% 32.90% 31.01% 29.67% 27.04% 16.40% 14.66% 20.59% 17.31%
Operating Return on Assets (OROA)		 18.20% 15.48% 17.57% 16.22% 18.79% 16.54% 21.10% 20.42% 24.61% 25.99% 24.21%
Return on Assets (ROA)		 13.46% 12.55% 13.76% 12.33% 14.55% 14.62% 15.30% 16.34% 18.77% 20.73% 21.52%
Return on Common Equity (ROCE)		 30.40% 13.93% 15.63% 13.41% 16.49% 16.34% 17.91% 18.73% 22.12% 24.44% 25.92%
Return on Equity Simple (ROE_SIMPLE)		 9.76% 10.24% 0.00% 15.59% 15.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 1.61 1.40 1.71 1.34 1.86 1.77 2.11 2.03 2.68 2.93 3.28
NOPAT Margin		 11.73% 10.10% 11.53% 9.13% 11.42% 11.31% 12.13% 12.04% 14.18% 15.75% 16.91%
Net Nonoperating Expense Percent (NNEP)		 1.31% 0.99% 1.02% 1.30% 0.83% 0.87% 0.60% 0.73% 0.54% 0.48% 0.65%
Return On Investment Capital (ROIC_SIMPLE)		 3.98% 3.29% - - 4.26% 4.04% 4.88% 4.55% 5.90% 5.95% 6.08%
Cost of Revenue to Revenue		 22.97% 25.15% 23.81% 21.66% 22.32% 22.03% 21.67% 21.85% 21.58% 21.17% 21.29%
SG&A Expenses to Revenue		 59.72% 60.37% 59.26% 64.00% 60.50% 62.56% 59.12% 60.91% 57.23% 56.61% 57.33%
R&D to Revenue		 0.78% 1.20% 1.19% 1.13% 1.54% 1.77% 1.74% 1.43% 2.03% 1.94% 1.69%
Operating Expenses to Revenue		 60.50% 61.57% 60.45% 65.13% 62.04% 64.33% 60.85% 62.34% 59.26% 58.56% 59.02%
Earnings before Interest and Taxes (EBIT)		 2.26 1.84 2.34 1.94 2.54 2.14 3.04 2.67 3.62 3.77 3.83
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2.47 2.05 2.55 2.16 2.81 2.42 3.44 2.93 3.88 4.05 4.10
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.32 3.27 2.92 4.47 5.73 4.65 4.27 4.58 5.35 3.94 6.49
Price to Tangible Book Value (P/TBV)		 2.36 3.32 2.96 4.54 5.81 4.71 4.30 4.62 5.39 3.97 6.53
Price to Revenue (P/Rev)		 1.81 2.60 2.38 3.25 4.19 3.32 2.88 3.10 3.53 2.70 4.75
Price to Earnings (P/E)		 23.78 31.91 25.26 28.67 36.96 28.51 24.47 25.00 27.01 19.17 30.99
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.21% 3.13% 3.96% 3.49% 2.71% 3.51% 4.09% 4.00% 3.70% 5.22% 3.23%
Enterprise Value to Invested Capital (EV/IC)		 2.78 4.12 4.00 6.21 8.54 6.58 6.06 6.23 7.24 5.49 9.84
Enterprise Value to Revenue (EV/Rev)		 1.61 2.38 2.08 3.01 3.92 3.08 2.64 2.88 3.33 2.46 4.47
Enterprise Value to EBITDA (EV/EBITDA)		 14.32 19.40 15.36 18.61 24.43 19.01 15.61 16.45 18.09 12.36 22.05
Enterprise Value to EBIT (EV/EBIT)		 16.34 22.18 17.33 20.49 27.00 21.10 17.51 18.37 19.97 13.50 23.76
Enterprise Value to NOPAT (EV/NOPAT)		 22.14 30.93 23.67 28.34 37.07 28.30 23.89 24.54 26.63 18.13 30.19
Enterprise Value to Operating Cash Flow (EV/OCF)		 17.09 22.82 12.58 14.77 20.68 15.71 14.84 20.63 25.10 16.78 34.12
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 43.89 16.97 17.71 26.29 21.38 22.19 39.95 52.96 28.19 62.03
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.26 -0.23 -0.28 -0.26 -0.32 -0.31 -0.36 -0.32 -0.34 -0.35 -0.37
Leverage Ratio		 1.16 1.16 1.19 1.17 1.18 1.17 1.21 1.19 1.20 1.20 1.24
Compound Leverage Factor		 1.21 1.24 1.28 1.28 1.25 1.25 1.26 1.25 1.24 1.23 1.28
Debt to Total Capital		 0.12% 0.07% 0.03% 0.02% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.12% 0.07% 0.03% 0.02% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.88% 99.93% 99.97% 99.98% 99.99% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -1.79 -1.78 -2.16 -1.50 -1.70 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -2.76 -2.84 -3.34 -2.29 -2.57 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 11.19 15.83 12.82 17.69 20.02 17.12 13.14 16.65 18.22 14.09 19.83
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.97 6.53 5.75 5.53 5.10 5.19 4.31 5.09 4.86 4.91 4.69
Quick Ratio		 5.08 5.63 5.13 4.88 4.50 4.54 3.82 4.44 4.27 4.42 4.11
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -28 0.19 3.61 4.97 4.44 3.93 2.65 -0.97 -1.60 -0.55 -2.32
Operating Cash Flow to CapEx		 4,888.73% 1,589.41% 20,404.55% 6,240.54% 1,352.36% 0.00% 2,661.38% 67.06% 477.29% 2,364.63% 1,367.12%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.10 1.17 1.12 1.23 1.20 1.21 1.21 1.29 1.28 1.28 1.23
Accounts Receivable Turnover		 2.25 2.31 2.31 2.49 2.61 2.60 2.67 2.81 2.81 2.78 2.71
Inventory Turnover		 2.55 3.31 3.27 3.37 3.53 3.86 4.00 4.04 4.59 4.94 4.54
Fixed Asset Turnover		 9.61 9.92 10.10 10.83 11.26 12.17 12.96 13.27 13.20 14.32 14.86
Accounts Payable Turnover		 11.67 12.13 10.91 9.39 10.86 10.33 7.63 5.91 7.84 6.92 5.96
Days Sales Outstanding (DSO)		 162.32 157.79 158.31 146.55 140.07 140.65 136.86 129.87 129.96 131.48 134.73
Days Inventory Outstanding (DIO)		 143.07 110.32 111.45 108.26 103.51 94.56 91.20 90.42 79.60 73.89 80.46
Days Payable Outstanding (DPO)		 31.29 30.09 33.47 38.86 33.62 35.35 47.83 61.77 46.57 52.78 61.21
Cash Conversion Cycle (CCC)		 274.09 238.01 236.30 215.95 209.95 199.87 180.23 158.52 162.98 152.59 153.98
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 30 31 28 28 27 29 28 31 32 32 34
Invested Capital Turnover		 3.45 1.77 1.86 1.94 2.08 2.06 2.27 2.27 2.33 2.36 2.40
Increase / (Decrease) in Invested Capital		 30 1.22 -1.90 -3.63 -2.59 -2.16 -0.54 3.00 4.28 3.48 5.61
Enterprise Value (EV)		 83 127 114 172 234 189 169 191 229 177 330
Market Capitalization		 94 139 130 185 250 204 184 205 243 194 350
Book Value per Share		 $4.70 $4.94 $5.15 $4.80 $5.16 $5.14 $5.15 $5.36 $5.45 $5.94 $6.52
Tangible Book Value per Share		 $4.63 $4.87 $5.07 $4.73 $5.08 $5.07 $5.11 $5.31 $5.40 $5.90 $6.47
Total Capital		 40 43 45 41 44 44 43 45 45 49 54
Total Debt		 0.05 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.05 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -10 -12 -16 -14 -16 -15 -15 -14 -14 -17 -20
Capital Expenditures (CapEx)		 0.07 0.09 0.02 0.04 0.23 -0.15 0.15 0.25 0.63 0.15 0.22
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 22 23 20 20 19 20 19 22 22 23 25
Debt-free Net Working Capital (DFNWC)		 33 35 36 34 36 36 35 36 36 40 45
Net Working Capital (NWC)		 33 35 36 34 36 36 35 36 36 40 45
Net Nonoperating Expense (NNE)		 -0.07 -0.09 -0.12 -0.13 -0.11 -0.12 -0.09 -0.10 -0.08 -0.08 -0.12
Net Nonoperating Obligations (NNO)		 -10 -12 -16 -14 -16 -15 -15 -14 -14 -17 -20
Total Depreciation and Amortization (D&A)		 0.21 0.21 0.21 0.22 0.27 0.28 0.40 0.26 0.26 0.29 0.27
Debt-free, Cash-free Net Working Capital to Revenue		 43.06% 43.52% 37.31% 34.57% 32.35% 33.28% 30.20% 32.75% 32.53% 32.08% 33.47%
Debt-free Net Working Capital to Revenue		 63.24% 65.42% 66.70% 58.87% 59.57% 58.08% 54.08% 54.06% 52.56% 55.75% 61.19%
Net Working Capital to Revenue		 63.24% 65.42% 66.70% 58.87% 59.57% 58.08% 54.08% 54.06% 52.56% 55.75% 61.19%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.20 $0.17 $0.21 $0.17 $0.23 $0.22 $0.27 $0.26 $0.33 $0.37 $0.41
Adjusted Weighted Average Basic Shares Outstanding		 8.55M 8.57M 8.56M 8.56M 8.42M 8.50M 8.45M 8.32M 8.27M 8.21M 8.27M
Adjusted Diluted Earnings per Share		 $0.19 $0.17 $0.20 $0.16 $0.22 $0.21 $0.26 $0.25 $0.32 $0.35 $0.38
Adjusted Weighted Average Diluted Shares Outstanding		 8.80M 8.89M 8.86M 8.98M 8.95M 8.97M 8.91M 8.68M 8.69M 8.65M 8.69M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 8.61M 8.66M 8.64M 8.46M 8.56M 8.39M 8.35M 8.34M 8.28M 8.28M 8.37M
Normalized Net Operating Profit after Tax (NOPAT)		 1.61 1.40 1.71 1.34 1.86 1.77 2.11 2.03 2.68 2.93 3.28
Normalized NOPAT Margin		 11.73% 10.10% 11.53% 9.13% 11.42% 11.31% 12.13% 12.04% 14.18% 15.75% 16.91%
Pre Tax Income Margin		 17.23% 14.14% 16.84% 14.54% 16.57% 14.55% 18.25% 16.60% 19.73% 20.81% 20.40%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 5.34% 74.37% 71.14% 92.25% 132.68% 78.88% 102.65% 75.09% 34.67%

Financials Breakdown Chart

Key Financial Trends

Electromed’s financial performance has strengthened considerably across the provided period. Quarterly revenue increased from $12.3 million in Q1 2024 to $19.4 million in Q4 2026, while net income rose from $155,000 to $3.4 million. Growth remained positive on a year-over-year basis in each comparable 2026 quarter, although the pace moderated to 11.6% in Q4 2026.

Profitability has improved alongside revenue growth. Gross margin generally remained near 77% to 79%, while operating margin expanded from just 1.2% in Q1 2024 to 19.7% in Q4 2026. Diluted earnings per share also increased from $0.02 to $0.38 over the same period. The latest quarter benefited from a relatively low tax expense compared with the prior quarter, so investors should distinguish between underlying operating improvement and quarterly tax-rate fluctuations.

Electromed also maintains a strong balance sheet. Cash increased from $7.0 million at September 30, 2023, to $17.0 million at March 31, 2026, and total equity reached $49.2 million. Total liabilities were only $10.3 million, with just $81,000 of noncurrent liabilities reported. Operating cash flow was positive in every provided quarter except Q1 2024, reaching $3.0 million in Q4 2026.

  • Sustained revenue growth: Quarterly revenue rose approximately 57% from Q1 2024 to Q4 2026, with comparable 2026 quarters continuing to post year-over-year gains.
  • Significant margin expansion: Operating margin improved from 1.2% in Q1 2024 to approximately 19.7% in Q4 2026, indicating stronger operating leverage.
  • Higher earnings and EPS: Q4 2026 net income of $3.4 million and diluted EPS of $0.38 were the highest levels in the provided data.
  • Healthy cash generation: Operating cash flow totaled $3.0 million in Q4 2026, compared with $1.4 million in Q3 2024, and exceeded net income in several earlier quarters.
  • Strong liquidity and limited leverage: At March 31, 2026, current assets of $50.2 million substantially exceeded current liabilities of $10.2 million, while noncurrent liabilities were minimal.
  • Share-count reduction: Basic weighted-average shares declined from about 8.56 million in Q1 2024 to 8.27 million in Q4 2026, helped by common-stock repurchases.
  • Working-capital volatility: Changes in operating assets and liabilities reduced operating cash flow by $1.4 million in Q4 2026 and $2.6 million in Q1 2026, despite both quarters being profitable.
  • Accounts receivable growth: Receivables increased from $23.5 million at September 30, 2023, to $28.3 million at March 31, 2026. This is consistent with higher sales but warrants monitoring for collection efficiency.
  • Cash flow has been affected by buybacks: Repurchases of common stock reduced cash by $2.8 million in Q2 2026 and $3.7 million in Q4 2025, limiting the amount of cash retained for investment or other uses.
  • Quarterly results include restatements and unusual items: Several prior-period income statements are marked as restated, and Q4 2026 includes $704,000 of noncash adjustments and $694,000 of other financing activities. Investors should review the company’s filings before extrapolating the latest figures.
09/09/26 07:47 AM ETAI Generated. May Contain Errors.

Electromed Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Electromed's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

Electromed's net income appears to be on an upward trend, with a most recent value of $11.30 million in 2026, rising from $2.21 million in 2016. The previous period was $7.54 million in 2025. Find out what analysts predict for Electromed in the coming months.

Electromed's total operating income in 2026 was $13.88 million, based on the following breakdown:
  • Total Gross Profit: $57.94 million
  • Total Operating Expenses: $44.06 million

Over the last 10 years, Electromed's total revenue changed from $22.99 million in 2016 to $73.78 million in 2026, a change of 220.9%.

Electromed's total liabilities were at $12.29 million at the end of 2026, a 16.0% increase from 2025, and a 191.3% increase since 2016.

In the past 10 years, Electromed's cash and equivalents has ranged from $5.12 million in 2016 to $20.45 million in 2026, and is currently $20.45 million as of their latest financial filing in 2026.

Over the last 10 years, Electromed's book value per share changed from 2.00 in 2016 to 6.52 in 2026, a change of 226.3%.


Related Companies

Financial statements for NYSE:ELMD last updated on 8/25/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel